Intracerebroventricular administration of ouabain as a model of mania in rats

Bipolar Disorders

Volumn 5, Issue 5, 2003, Pages 362-365

  El Mallakh, Rif S ^a   El Masri, M Adnan ^a   O'Malley Huff, Mary ^a   Li, Xiao Ping ^a   Decker, Sarah ^a   Levy, Robert S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bipolar illness; Mania animal model; Mania model; Manic depressive illness; Ouabain; Sodium pump; Sodium and potassium activated adenosine triphosphatase (Na, K ATPase)

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATION; LITHIUM CARBONATE; OUABAIN; SODIUM ION; TD 87062; TRANQUILIZER;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; CELL TRANSPORT; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG SCREENING; IN VIVO STUDY; ION TRANSPORT; MALE; MANIA; MOOD; NONHUMAN; OPEN FIELD BEHAVIOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM CELL LEVEL;

ANIMALS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; LITHIUM; LOCOMOTION; MALE; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0242269060     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2003.00053.x     Document Type: Article

References (26)

1. Dubovsky SL, Christiano J, Daniell LC et al. Increased intracellular calcium concentration in patients with bipolar affective disorder. Arch Gen Psychiatry 1989; 46: 632-638.
2. Dubovsky SL, Lee C, Christiano J, Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry 1991; 29: 441-450.
3. Dubovsky SL, Murphy J, Thomas M, Mademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 1992; 149: 118-120.
4. Emamghoreishi M, Li PP, Schlichter L, Parikh S, Cooke RG, Warsh JJ. Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder. Biol Psychiatry 2000; 48: 665-673.
5. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Warsh JJ. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997; 154: 976-982.
6. Hough C, Lu S-J, Davis CL, Chuang D-M, Post RM. Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay. Biol Psychiatry 1999; 46: 247-255.
7. Coppen A, Shaw DM, Malleson A, Costain R. Mineral metabolism in mania. Br Med J 1966; 1: 71-75.
8. Shaw DM. Mineral metabolism, mania, and melancholia. Br Med J 1966; 2: 262-267.
9. Knorring L, Oreland L, Perris C, Wilberg Å. Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders. Phramakopsychiatrie 1976; 9: 81-94.
10. Rybakowski J, Frazer A, Mendels J, Ramsey TA. Frythrocyte accumulation of the lithium ion in control subjects and patients with primary affective disorder. Comm Psychopharmacol 1978; 2: 99-104.
11. Ramsey TA, Frazer A, Mendels J, Dyson WL. The erythrocyte lithium-plasma lithium ratio in patients with primary affective disorder. Arch Gen Psychiatry 1979; 36: 457-461.
12. Szentistvany I, Janka Z, Szilard J. Clinical significance of sodium-dependent lithium transport in affective psychoses. Psychiatria Clin 1980; 13: 57-64.
13. Looney SW, El-Mallakh RS. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depr Anxiety 1997; 5: 53-65.
14. Rose AM, Mellett BJ, Valdes R Jr et al. Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998; 44: 892-897.
15. Grider G, El-Mallakh RS, Huff MO, Buss TJR, Miller J, Valdes R Jr. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999; 54: 261-267.
16. El-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry 1995; 37: 235-244.
17. +-ATPase the link between phosphoinositide metabolism and bipolar disorder? J Neuropsychiatry Clin Neurosci 1993; 5: 361-368.
18. El-Mallakh RS, Harrison LT, Li R, Changaris DG, Levy RS. An animal model for mania: preliminary results. Prog Neuro-Psychopharmacol Biol Psychiatry 1995; 19: 955-962.
19. Decker S, Grider G, Cobb M et al. Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Prog Neuro-Psychopharmacol Biol Psychiatry 2000; 24: 455-462.
20. Ruktanochai DJ, El-Mallakh RS, Li R, Levy RS. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol Behav 1998; 63: 403-406.
21. Changaris DG, Porter JL, Miller JJ, Levy RS. Des-Leu angiotensin I: biosynthesis and drinking response. Regul Pept 1988; 20: 273-280.
22. Cooper DA, Piper DC, Upton N, Leslie RA. The effect of lithium on the hypermotility response to the central administration of ouabain in the rat. Br J Pharmacol 1996; 118 (suppl): 62P.
23. Piper DC, Cooper DA, Upton N. The Effect of Antimanic Drugs on the Hyperlocomotor Response to ICV Administration of Ouabain in the Rat. Presented at the Annual Meeting of the European College of Neuropsychopharmacology. Amsterdam, Netherlands, 1996.
24. Li R, El-Mallakh RS, Harrison L, Changaris DG, Levy RS. Lithium prevents ouabain-induced behavioral changes: toward an animal model for manic depression. Mol Chem Neurophathol 1997; 31: 65-72.
25. El-Mallakh RS, Pant B, Looney SW. Nerve conduction velocity and H-reflex recovery in bipolar illness. J Neuropsychiatry Clin Neurosci 1996; 8: 412-416.
26. James PF, Grupp IL, Grupp G et al. Identification of a specific role for the Na,K-ATPase alpha 2 isoforms as a regulator of calcium in the heart. Molec Cell 1999; 3: 555-563.